1359656-25-9 Usage
Uses
Used in Pharmaceutical Industry:
Tert-butyl 1-(4-nitrophenyl)cyclobutylcarbaMate is used as a pharmaceutical intermediate for the synthesis of various drugs. Its unique structure and potential biological activities make it a promising candidate for the development of new therapeutic agents.
Used in Agrochemical Industry:
In the agrochemical industry, tert-butyl 1-(4-nitrophenyl)cyclobutylcarbaMate is used as a precursor for the synthesis of pesticides and other agrochemicals. Its structural features and potential biological activities can contribute to the development of effective and environmentally friendly agrochemical products.
Used in Materials Science:
Tert-butyl 1-(4-nitrophenyl)cyclobutylcarbaMate is used as a building block in the synthesis of advanced materials with specific properties. Its cyclobutyl ring structure and functional groups can be utilized to create materials with unique physical, chemical, and biological properties for various applications in materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 1359656-25-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,5,9,6,5 and 6 respectively; the second part has 2 digits, 2 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1359656-25:
(9*1)+(8*3)+(7*5)+(6*9)+(5*6)+(4*5)+(3*6)+(2*2)+(1*5)=199
199 % 10 = 9
So 1359656-25-9 is a valid CAS Registry Number.
1359656-25-9Relevant academic research and scientific papers
NOVEL SUBSTITUTED CYCLOBUTYLBENZENE COMPOUNDS AS INDOLEAMINE 2,3-DIOXYGENASE (IDO) INHIBITORS
-
Page/Page column 48, (2019/05/02)
Disclosed herein is a compound of formula (I), or a pharmaceutically acceptable salt thereof: (Formula (I)). Also disclosed herein are uses of a compound disclosed herein in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising a compound disclosed herein. Further disclosed herein are uses of a composition in the potential treatment or prevention of an IDO-associated disease or disorder.
PROCESS OF PREPARING 3-(3-(4-(1-AMINOCYCLOBUTYL)PHENYL)-5-PHENYL-3H-IMIDAZO[4,5-B]PYRIDIN-2-YL)PYRIDIN-2-AMINE
-
Paragraph 0180, (2015/11/03)
The present invention is directed to a processes for the synthesis of 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3H-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine:
